Funding, M&A, exec moves and hiring — matched to your market, with the people to call.See plans →
Meduloc Closes $4 Million Series B Financing Led By Gen Henn Capital To Support Its Innovative Fracture Fixation Platform Launch. announced it raised $4 Million in an initial filing from an offering of $1.84 Million
PRIVATEAug 06, 2026•3 days ago
Amount Raised
$4 Million
Round Type
Series B
Del MarHealthcareInvestors
Andre EthierBroad Street AngelsBen Franklin Technology Partners Of Southeastern PennsylvaniaLife Sciences Greenhouse InvestmentsGen Henn Capital
Description
Meduloc, an orthopedic medical device company, has announced its $4 million Series B financing. The round was led by GenHenn Capital with strong support from several Pennsylvania investors. The funding will facilitate Meduloc's controlled alpha launch and development of commercial infrastructure. This marks a significant milestone for Meduloc as they transition into commercialization.
Related People
Suggested for you
2 contactsVerified contactsSarah, Chief Executive Officer and President hidden
Funding Insights
Based on industry dataTimeline to next round
Series B companies typically work for 15-20 months before raising new capital
Growth expectations
Series B companies are expected to scale rapidly and expand market reach
VC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers